Search

everythinglearnresearchcommunity

for

Search:↓

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Men with male pattern baldness have increased arterial stiffness.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Finasteride helps hair growth but stopping it causes faster hair loss.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Patients with pernio have lower vitamin B12 and ferritin levels than healthy people.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Low iron levels are linked to hair loss in women.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with high androgen levels may have more severe COVID-19 symptoms.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.